Q4 EPS Estimate for United Therapeutics Lowered by Analyst
Equities research analysts at Leerink Partnrs dropped their Q4 2024 earnings per share estimates for United Therapeutics in a ...
Gossamer Bio Is A Good Speculative Buy On Seralutinib For PAH And PH-ILD
Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...
Research Analysts Issue Forecasts for UTHR FY2024 Earnings
Leerink Partnrs dropped their FY2024 earnings per share estimates for shares of United Therapeutics in a research report ...